Bromma, Sweden

Per Hellstrom

USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Per Hellstrom

Introduction

Per Hellstrom is a notable inventor based in Bromma, Sweden. He has made significant contributions to the field of medical treatments, particularly in addressing functional dyspepsia and irritable bowel syndrome. His innovative approach has led to the development of a unique method that enhances the efficacy of treatment for these conditions.

Latest Patents

Per Hellstrom holds a patent for a formulation known as Val (8) GLP-1 composition. This patent outlines a method for treating functional dyspepsia and/or irritable bowel syndrome in mammals. The method involves administering a formulation by inhalation, which effectively avoids first-pass metabolism of the active ingredient. This innovative approach utilizes a diketopiperazine and a glucagon-like peptide (GLP-1) analog, specifically ROSE-010, to provide a more effective treatment option.

Career Highlights

Throughout his career, Per Hellstrom has been associated with Mannkind Corporation, where he has contributed to the advancement of medical therapies. His work has focused on developing inhalable formulations that improve patient outcomes. His dedication to innovation in the medical field has positioned him as a key figure in the industry.

Collaborations

Per Hellstrom has collaborated with notable colleagues, including Peter Richardson and Enda Kenny. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in medical technology.

Conclusion

Per Hellstrom's contributions to the field of medical inventions, particularly through his patented methods for treating gastrointestinal disorders, highlight his innovative spirit and commitment to improving patient care. His work continues to influence the development of effective treatments in the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…